FIERCELY
FOCUSED

on the development of novel
treatments for patients with
B-cell malignancies and
autoimmune diseases.

Learn
about us

Explore our
pipeline

investor
Information

Read our
publications

Latest News

TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2019 Financial Results and Business Update

Investor Conference Call to be held Tuesday, March 3, 2020 at 8:00 AM ET NEW YORK , Feb. 28, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held on Tuesday March 3, 2020 at 8:00 AM ET to discuss results for the fourth quarter and

Read More >

2 Gansevoort Street, 9th Floor
New York, NY 10014

Email Us (212) 554-4484